AB287109
MW 511.6 Da, Purity >98%. A potent and selective Nrf2 inhibitor (Nrf2; IC50 = 1.9 μM). ML-385 blocks Nrf2 downstream target gene expression. ML-385 displays specificity and selectivity for NSCLC cells with KEAP1 mutation, which leads to gain of Nrf2 function.
Product details
This product is manufactured by BioVision, an Abcam company and was previously called B2605 ML-385. B2605-25 is the same size as the 25 mg size of ab287109.
Properties and storage information
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
It is important to note that this product is reported to be light sensitive|Store in the dark
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Renal failure 45:2165103 PubMed36938748
2023
Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway.
Applications
Unspecified application
Species
Unspecified reactive species
Chenlei Lv,Tianyang Cheng,Bingbing Zhang,Ke Sun,Keda Lu
ACS chemical biology 11:3214-3225 PubMed27552339
2016
Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors.
Applications
Unspecified application
Species
Unspecified reactive species
Anju Singh,Sreedhar Venkannagari,Kyu H Oh,Ya-Qin Zhang,Jason M Rohde,Li Liu,Sridhar Nimmagadda,Kuladeep Sudini,Kyle R Brimacombe,Sachin Gajghate,Jinfang Ma,Amy Wang,Xin Xu,Sampada A Shahane,Menghang Xia,Juhyung Woo,George A Mensah,Zhibin Wang,Marc Ferrer,Edward Gabrielson,Zhuyin Li,Fraydoon Rastinejad,Min Shen,Matthew B Boxer,Shyam Biswal
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com